David G. Song

David Song practices at David G Song MD Inc in Chino, California.

David Song's NPI, 1699115972, was assigned on July 1, 2013. David Song graduated from Saint Louis University School Of Medicine in 2013. David Song's Missouri license number on file is 2013018892.

David Song's primary practice is David G Song MD Inc, at 5365 Walnut Ave, Chino, CA 91710 in San Bernardino County. The practice phone is (909) 902-0009.

David Song's primary practice is David G Song MD Inc in Chino, California. David Song is also affiliated with Chino Valley Medical Center. The medical group on file is Access Urology. Dmand AI also links David Song to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where David Song practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is David Song's primary specialty in the NPI Registry, under taxonomy code 208800000X. David Song is board certified in urology by the American Board of Urology. Dmand AI has David Song's licenses on file in 2 states: Missouri and California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney disease, kidney removal surgery and kidney stone disease among the conditions David Song treats.

CMS data shows 6,661 Medicare services from David Song across 15 procedure codes in 2024, for 768 Medicare patients. Medicare paid $421,625 for them.

CMS counts 768 Medicare patients who saw David Song in 2024. The largest group is 65 to 74, with 349 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 63% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts David Song's median patient age at 64, with 29% women.

In 2024, David Song wrote 6,061 Medicare Part D claims for 1,558 patients. 89% of them were for generic drugs. CMS names the drug for 5,955 of them, across 32 drugs with 11 or more claims each, at $1,352,809 in total drug cost. In 2023, CMS named 3,196 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for David Song for performance year 2024, reported individually. David Song accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists David Song as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to David Song in 2013. David Song's most frequent co-authors are Gerald L. Andriole, MD and Carol S. North, MD.

CMS Open Payments shows 286 general payments to David Song from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 64% of the total. Boston Scientific Corporation paid the most, $3,096.

David Song graduated from Saint Louis University School Of Medicine in 2013.

David Song is in network with 16 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.